Moolec Science price target lowered to $3 from $6 at Maxim

Maxim lowered the firm’s price target on Moolec Science to $3 from $6 but keeps a Buy rating on the shares. The analyst cites the company’s Q4 earnings loss coming in wider than expected despite better than anticipated revenue. Maxim adds that its lowered expectations for offtake and commercialization of Moolec’s ValoraSoy textured soy ingredient product is driving a reduction in its revenue expectations for the company, even though it sees the stock’s valuation premium relative to peers as justified due to the company’s “superior technology and significant market opportunity”.